Skip to main content
Premium Trial:

Request an Annual Quote

Sangtec Molecular Licenses DxS s Scorpions Technology

NEW YORK, Feb. 18 (GenomeWeb News) -  Sangtec Molecular Diagnostics has licensed the Scorpions genotyping technology from DxS in order to develop in vitro  diagnostics, the companies said today.

Financial details of the deal were not disclosed.

Scorpions is a fluorescence-based nucleic acid detection and genotyping system developed by DxS, a genetic analysis services provider. 

 

Stockholm, Sweden-based Sangtec is a subsidiary of Altana Pharma of Bad Homburg, Germany.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.